Biomea Fusion Inc
(NAS:BMEA)
$
4.35
-0.08 (-1.81%)
Market Cap: 156.36 Mil
Enterprise Value: 22.53 Mil
PE Ratio: 0
PB Ratio: 1.16
GF Score: 40/100 Biomea Fusion Inc (BMEA) Transcripts
- Biomea Fusion Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Biomea Fusion Inc ADA Scientific Sessions Discussion TranscriptJun 27, 2023
- Biomea Fusion Inc to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes- Conference Call TranscriptMar 28, 2023
- Biomea Fusion Inc to Discuss FDA Clearance of IND for BMF-219 in Type 2 Diabetes TranscriptDec 15, 2022
- Biomea Fusion Inc Covalent Menin Inhibitor BMF-219's Activity in Diabetes as Presented at the 82nd American Diabetes Association Annual Conference TranscriptJun 06, 2022
- 1